CD20-positive Hematological Malignancies
1 clinical trials · Condition
◉ Watch CD20-positive Hematological Malignancies
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies (NCT07110194) | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 2025-09-01 |
Track CD20-positive Hematological Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.